Page last updated: 2024-09-02

kt 6149 and Carcinoma

kt 6149 has been researched along with Carcinoma in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ardiet, C; Catimel, G; De Bruijn, E; Dirix, L; Tranchand, B; Van Oosterom, A; Verdonk, R1
Abe, O; Arisawa, Y; Inada, T; Inoue, S; Ishibiki, K; Kodaira, S; Kubota, T; Kuzuoka, M; Suto, A1

Trials

1 trial(s) available for kt 6149 and Carcinoma

ArticleYear
Phase I and pharmacokinetic study of KW-2149 given by 24 hours continuous infusion.
    Investigational new drugs, 1995, Volume: 13, Issue:2

    Topics: Antineoplastic Agents; Carcinoma; Colorectal Neoplasms; Dose-Response Relationship, Drug; Drugs, Investigational; Female; Humans; Infusions, Intravenous; Lung; Male; Middle Aged; Mitomycin; Mitomycins; Ovarian Neoplasms

1995

Other Studies

1 other study(ies) available for kt 6149 and Carcinoma

ArticleYear
Antitumor activity of 7-N-(2-((2-(gamma-L-glutamylamino) ethyl) dithio) ethyl) mitomycin C (KW2149) against human tumor xenografts serially transplanted into nude mice.
    Japanese journal of clinical oncology, 1989, Volume: 19, Issue:3

    Topics: Adenocarcinoma; Adenocarcinoma, Papillary; Animals; Antineoplastic Agents; Carcinoma; Carcinoma, Intraductal, Noninfiltrating; Dose-Response Relationship, Drug; Humans; Injections, Intraperitoneal; Injections, Intravenous; Male; Mice; Mice, Inbred A; Mice, Inbred BALB C; Mice, Nude; Mitomycin; Mitomycins; Neoplasm Transplantation; Random Allocation; Transplantation, Heterologous

1989